Table 1.

Demographic and Headache Characteristics of Ketorolac vs Sumatripan vs Placebo Nasal Spray Migraine Study Participants

Characteristics			n	%
Age	Mean (SD)	36.3 (9.8)
Race	Caucasian		43	79.6
	African American		7	12.9
	Other		4	7.4
Sex	Female		53	98.1
	Male		1	1.9
Marital status	Single		20	37.0
	Married		27	50.0
	Other		7	13.0
Education	HS		17	1.5
	College		24	44.4
	Post Grad		12	44.2
	Unknown		1	1.9
Income	<50 K		18	33.3
	>50 K		35	64.8
	Unknown		1	1.9
Baseline HA Characteristics
Age at 1st HA	Median (IQR)	12 (6)
Age at Mig Dx	Median (IQR)	22 (14)
Monthly HA frequency	Median (IQR)	6 (4)
ASC total	Median (IQR)	2 (6)
HIT-6 total	Mean (SD)	60.4 (7.7)
Acute Attack HA Characteristics (Pretreatment)
Nausea			25	46.3
Vomiting			1	1.3
Photophobia			42	78.3
Phonophobia			38	70.4
Aura			14	28.6
Number of alloydnia sx	Median (IQR)	1 (2)
Disability	Mild		19	37.5
	Moderate/Severe		23	45.4

Dx = diagnosis; HA = headache; IQR = interquartile ratio; SD = standard deviation; sx = symptoms.